The tweet was deleted by the author.
But we saved everything 🙂.
Afzal Lokhandwala, market commentator and trader at FinTwit / Social Media, observes that biotech stocks are gaining momentum. Multiple stocks in the sector are aligning, with both price and volume action confirming the synchronized movement. Lokhandwala identifies RCUS as the leading name in this emerging sector theme.
Lokhandwala has recently highlighted sharp declines in major indices, noting the S&P 500's steep fall as the U.S. stock market's worst day since October in a June report. He has also reported that Infosys, TCS, and Wipro each lost over 25% since February, according to a review of IT sector losses. These observations come as he now tracks the rising momentum in biotech stocks.